Identification of an MiRNA-mRNA Regulatory Network in Colorectal Cancer

Ming-Fu Cui1, Yuan-Yu Wu2, Ming-Yan Chen3

  • 1Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, China.

Abstract

Insights

This study identifies key microRNAs (miRNAs) and genes involved in colorectal cancer (CRC) pathogenesis. Specific molecules like miR-27a-3p and GRIN2B may offer new diagnostic and prognostic insights for CRC.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • Colorectal cancer (CRC) is a major global health concern, ranking as the fourth most common cancer worldwide.
  • The intricate molecular mechanisms driving CRC development and progression remain largely unelucidated, hindering effective diagnosis and treatment strategies.

Purpose of the Study:

  • To elucidate the molecular pathogenesis of colorectal cancer.
  • To identify potential biomarkers for improved diagnosis and therapeutic targeting of CRC.

Main Methods:

  • Screening of differentially expressed microRNAs (DEMs) and genes (DEGs) in CRC versus control samples using TCGA-COAD and GSE115513 datasets.
  • Construction of a miRNA-mRNA regulatory network, followed by functional enrichment, pathway analysis, and protein-protein interaction (PPI) network analysis.
  • Survival analysis was conducted to identify genes and miRNAs correlated with CRC prognosis.

Main Results:

  • Identification of 64 DEMs in GSE115513 and 265 DEMs and 2218 DEGs in TCGA-COAD.
  • miR-27a-3p emerged as a key regulatory miRNA, targeting hub genes GRIN2B and PCDH10. GRIN2B and SNAP25 were identified as significant nodes in the PPI network.
  • Enrichment analysis revealed involvement in pathways such as proteoglycans expression and cAMP signaling. Seven DEGs, including FJX1 and Dsc2, and hsa-miR-375 showed correlation with CRC prognosis.

Conclusions:

  • Aberrant gene and miRNA expression, particularly involving proteoglycans and cAMP signaling, contributes to CRC pathogenesis.
  • miR-27a-3p, PCDH10, GRIN2B, FJX1, Dsc2, and hsa-miR-375 are proposed as potential targets for understanding CRC mechanisms.
  • FJX1, Dsc2, and hsa-miR-375 demonstrate potential as predictive biomarkers for colorectal cancer patient outcomes.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K